January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Hervolution ApS
Proprietary technology to stimulate a potent immune response against previously un-druggable proteins in cancer, type-2 diabetes, and aging cells. These targets come from the human “dark genome” and have to-date avoided therapeutics